10-K
Annual Report
VITASPRING BIOMEDICAL CO., LTD.
CIK: 1697884
File #: 333-216645
Balance Sheet
27 line items · 2 periods
XBRL
| Item | Jan 31, 2025 | Jan 31, 2024 |
|---|---|---|
BALANCE SHEETS | ||
ASSETS | ||
CURRENT ASSETS | ||
Cash | 272 | 13 |
Other Current Assets | 0 | 23,614 |
Total current assets | 272 | 23,627 |
LONG-TERM ASSETS | ||
Property, Plant and Equipment | 14,106 | 24,063 |
Operating Lease Right-of-Use Asset | 0 | 89,652 |
Total long-term assets | 14,106 | 113,715 |
Total assets | 14,378 | 137,342 |
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
CURRENT LIABILITIES | ||
Accounts Payable | 2,411,000 | 2,411,000 |
Other Non-Operating Current Liabilities | 494,751 | 339,001 |
Taxes Payable | 313,722 | 218,714 |
Operating Lease Liability, Current | 0 | 93,334 |
Advances from related party | 810,105 | 425,482 |
Total current liabilities | 4,029,578 | 3,487,531 |
Total liabilities | 4,029,578 | 3,487,531 |
COMMITMENTS AND CONTINGENCIES | 0 | 0 |
STOCKHOLDERS' DEFICIT | ||
Total Stockholders' Equity | 20,703 | 20,703 |
Total Stockholders' Equity | 1,245,600 | 1,135,689 |
Total Stockholders' Equity | (5,281,503) | (4,506,581) |
Total stockholders' deficit | (4,015,200) | (3,350,189) |
Total liabilities and stockholders' deficit | 14,378 | 137,342 |